Medlive Technology Co., Ltd.
HKSE: 2192.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Liping Tian
- Employees
- 747
- Headquarters
- Beijing, China
- IPO year
- 2021
- Market cap
- HK$6.6B
- Website
- https://www.medlive.cn
Loading 2192…
Loading profile data…Frequently asked questions about 2192
What does Medlive Technology Co., Ltd. (2192.HK) do?
Medlive Technology Co., Ltd., together with its subsidiaries, operates an online professional physician platform in Mainland China and internationally. Its precision marketing and corporate solution provides full service on its one-site platform, which includes project management, clinical monitoring, clinical data management, biostatistics, pro...
Where does 2192.HK trade?
Medlive Technology Co., Ltd. (2192.HK) trades on the Hong Kong Stock Exchange.
What sector is 2192.HK in?
Medlive Technology Co., Ltd. (2192.HK) operates in the Healthcare sector, specifically in the Medical - Distribution industry.
Who is the CEO of Medlive Technology Co., Ltd.?
Liping Tian is the chief executive officer of Medlive Technology Co., Ltd. (2192.HK).
Where is Medlive Technology Co., Ltd. headquartered?
Medlive Technology Co., Ltd. is headquartered in China.
Does 2192.HK pay a dividend?
Yes — Medlive Technology Co., Ltd. (2192.HK) paid a trailing twelve-month dividend of HKD 0.28 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 2192.HK go public?
Medlive Technology Co., Ltd. (2192.HK) completed its initial public offering in 2021.